Kindly MD, Inc. (NAKA)
NASDAQ: NAKA · Real-Time Price · USD
0.4495
+0.0053 (1.19%)
Nov 25, 2025, 12:46 PM EST - Market open

Kindly MD Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21
1.982.723.773.792.5
Revenue Growth (YoY)
-31.13%-27.83%-0.49%51.22%-
Cost of Revenue
9.393.653.924.331.59
Gross Profit
-7.41-0.93-0.16-0.540.91
Selling, General & Admin
7.341.911.362.10.85
Research & Development
00.380--
Operating Expenses
7.452.421.462.150.85
Operating Income
-14.86-3.35-1.62-2.690.06
Interest Expense
-0.02-0.39-0.06--
Other Non Operating Income (Expenses)
-59.790.160.060.150.09
EBT Excluding Unusual Items
-74.92-3.58-1.62-2.540.15
Other Unusual Items
-14.45-0.04---
Pretax Income
-90.49-3.62-1.62-2.540.15
Net Income
-90.49-3.62-1.62-2.540.15
Net Income to Common
-90.49-3.62-1.62-2.540.15
Shares Outstanding (Basic)
56552-
Shares Outstanding (Diluted)
56552-
Shares Change (YoY)
999.74%19.79%177.24%--
EPS (Basic)
-1.63-0.67-0.36-1.56-
EPS (Diluted)
-1.63-0.67-0.36-1.56-
Free Cash Flow
-16.85-3.09-0.46-0.460.06
Free Cash Flow Per Share
-0.30-0.57-0.10-0.28-
Gross Margin
--34.02%-4.14%-14.31%36.53%
Operating Margin
-750.47%-123.05%-42.99%-71.12%2.45%
Profit Margin
-4569.52%-133.01%-42.92%-67.09%5.96%
Free Cash Flow Margin
-850.66%-113.51%-12.31%-12.09%2.31%
EBITDA
-14.76-3.21-1.51-2.640.07
EBITDA Margin
--118.03%-40.19%-69.71%2.64%
D&A For EBITDA
0.10.140.110.050
EBIT
-14.86-3.35-1.62-2.690.06
EBIT Margin
--123.05%-42.99%-71.12%2.45%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q